About
ProtonDx is a UK-based company founded in 2020 as a spinout from Imperial College London. It specializes in rapid, portable, and accurate molecular diagnostic solutions for human health, animal health, food safety, and life sciences research. The company is headquartered in London and was established by a team of experts, including Professor Pantelis Georgiou, Assistant Professor Jesus Rodriguez-Manzano, and Dr. Nicolas Moser. ProtonDx offers several innovative products, including the Dragonfly Molecular Diagnostic Platform, which allows for simultaneous detection of multiple pathogens in a portable format. Their SmartLid Extraction Kits streamline nucleic acid extraction, while TurboBeads enhance the efficiency of this process. The LyoLAMP test panel provides a customizable solution for molecular workflows. ProtonDx serves a diverse range of customers, focusing on improving diagnostics in various sectors, including public health, veterinary applications, food safety, and research institutions. Their commitment to combining engineering, medicine, and molecular biology drives their mission to enhance diagnostic accessibility and accuracy worldwide.
Technologies
Keywords
Company Information
-
Employees 25
-
Founded 2020
Location
84 Wood Lane, London, England, United Kingdom, NW9 7PA